Related Experiment Video
Updated: Apr 17, 2026
10:02
State of the Art Cranial Ultrasound Imaging in Neonates
Published on: February 2, 2015
26.7K
Special considerations in infants and children.
Ann-Christine Duhaime1, Rima Sestokas Rindler2
1Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Handbook of Clinical Neurology
|February 23, 2015
Summary
Pediatric head injury is a major cause of death and disability. Further research and large datasets are needed to optimize treatment and recovery for children with head injuries.
Area of Science:
- Pediatric Neurology
- Traumatology
- Neuroscience
Background:
- Head injury is a leading cause of death and disability in children globally.
- Pediatric head injury presents unique challenges compared to adult injuries.
Purpose of the Study:
- To review the causes, patterns, pathophysiology, and treatment of pediatric head injury.
- To compare head injury in children to that in adults.
- To highlight areas needing further research for optimal clinical interventions.
Main Methods:
- Review of existing literature on pediatric head injury.
- Discussion of classification systems (severity, pathoanatomic type, mechanism).
- Examination of age-specific neuroassessment tools and advanced imaging (MRI).
Main Results:
- Response and repair mechanisms in pediatric head injury vary by age.
- Specific management issues like intracranial pressure (ICP) monitoring and seizure prophylaxis are crucial.
- Functional outcomes and injury patterns in pediatric patients require further study.
Conclusions:
- Optimal treatment for pediatric head injury requires more research, especially for milder injuries.
- Large, collaborative international datasets are essential for understanding age-specific injury evolution.
- Future research should focus on pathophysiologic, treatment, and genetic factors influencing recovery.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
863
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
01:29Drug Dosing: Infants and Children
904
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
904
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
507
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
362
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362